# Quadria Capital

> Quadria Capital is a VC fund in Singapore backing Health Care and Medical. See 27 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 27
- Last investment: Jan 2025
- Lead investor: 67%
- Last fund: Dec 2022
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/2463054
- X (Twitter): http://twitter.com/QuadriaCapital
- Website: http://quadriacapital.com

Quadria Capital is a healthcare focused private equity fund that invests in the high growth healthcare sector of some of the world's fastest growing economies in South Asia and Southeast Asia. Quadria Capital aims to generate significant financial returns for its investors by leveraging the team's operational and transactional experiencein healthcare to invest in high quality and scalable healthcare organizations to address the critical and undersupplied healthcare needs in the region.

## Contacts

5 contacts available for Quadria Capital. Shizune tracks 3 team members at Quadria Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/quadria-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Private Equity | $13M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 14 | 52% |
| Medical | 7 | 26% |
| Manufacturing | 6 | 22% |
| Hospital | 5 | 19% |
| Pharmaceutical | 3 | 11% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 17 | 63% |
| Funding Round | 2 | 7% |
| Series A | 1 | 4% |
| Series C | 1 | 4% |
| Series F | 1 | 4% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 15 | 56% |
| Vietnam | 2 | 7% |
| Indonesia | 2 | 7% |
| Malaysia | 1 | 4% |
| United States | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Amit Varma | Co-founder & Managing Partner | 8 | https://shizune.co/investors/profile/amit-varma-1e74 |
| Sunil Thakur | Director | 6 | https://shizune.co/investors/profile/sunil-thakur |
| Abrar Mir | Founder & Managing Partner | 3 | https://shizune.co/investors/profile/abrar-mir |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aragen Life Sciences | GVK Biosciences (GVK BIO) is one of Asia’s leading Discovery Research and Development organizations. GVK BIO provides a broad spectrum of services, across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO capabilities include Integrated Programs, Discovery Services, Clinical Development, Contract Manufacturing,Formulations and Informatics.GVK BIO has over a decade of rich experience in providing breakthrough drug discovery and development services. Their team of scientists, backed by well-laid processes and cutting edge technologies, enable customers to achieve unmatched results.GVK BIO’s 2400 employees serve a diverse and global customer base of more than 300 satisfied customers. They have consistently exceeded their customers’ expectations in terms of quality, speed and affordability. Precisely why, their clientele who are among the global top 10 in the fields of Pharmaceutical, Agrochemical, Electronics, Biotechnology and Academics entrust us with their research challenges. | $100M | Private Equity | Jan 13, 2025 |  |
| NephroPlus | NephroPlus operates a network of dialysis centers with the goal of providing quality dialysis at low pricing through the use of standardized protocols, constant training, and focused innovation. The company's network provides dialysis, kidney stone treatment, arteriovenous fistula procedures, and other treatments linked to renal and urologicaldisorders. | $12M | Series F | May 03, 2024 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $18M |  | Aug 30, 2023 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $18M |  | Aug 30, 2023 |  |
| Maxivision Super Speciality Eye Hospitals | Maxivision Super Speciality Eye Hospitals is eye care hospital | $73.2M | Private Equity | Jul 12, 2023 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $125M | Series C | Feb 22, 2022 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $125M | Series C | Feb 22, 2022 |  |
| Concung | Concung Corporation is an extremely fast growing technology company for mom & baby products with one new store opened every day with the annual growth rate of 70%. By the end of 2022, the revenue is more than $500 million USD with 1,000 stores & 10 flagship hubs. Concung has more than millions of e-commerce users. With the vision ofproviding good quality products for moms, babies and kids from newborn to 12 year old. Con Cung addressable market size is more than 50 millions of population. It positions to cover all products and services for this market. As a tech company, Con Cung develops strong IT infrastructure for its e-commerce, hub/retail network, supply chain and operation/sales automation. Concung also invests into Research and Development in order to manufacture and provide products that are suitable and superior to the local market in terms of quality and pricing. All of the products must follow strict safety standards.With its extremely efficient management capability, the company is highly profitable with minimal capital investment. Con Cung maintains profitable even at the first year of establishment and shows to be a resilient business even during the Covid-19 pandemics. Concung Corporation is dynamic and vibrant. The management team are mostly in the age of 30s. Many of them are now holding the director positions with highly competitive benefit packages. The corporate culture is transparent, result oriented and fast decision making. The company nurtures and supports the creativity and originality of ideas. The working environment allows talents to prosper and promote quickly. | $90M | Private Equity | Jan 18, 2022 |  |
| Concung | Concung Corporation is an extremely fast growing technology company for mom & baby products with one new store opened every day with the annual growth rate of 70%. By the end of 2022, the revenue is more than $500 million USD with 1,000 stores & 10 flagship hubs. Concung has more than millions of e-commerce users. With the vision ofproviding good quality products for moms, babies and kids from newborn to 12 year old. Con Cung addressable market size is more than 50 millions of population. It positions to cover all products and services for this market. As a tech company, Con Cung develops strong IT infrastructure for its e-commerce, hub/retail network, supply chain and operation/sales automation. Concung also invests into Research and Development in order to manufacture and provide products that are suitable and superior to the local market in terms of quality and pricing. All of the products must follow strict safety standards.With its extremely efficient management capability, the company is highly profitable with minimal capital investment. Con Cung maintains profitable even at the first year of establishment and shows to be a resilient business even during the Covid-19 pandemics. Concung Corporation is dynamic and vibrant. The management team are mostly in the age of 30s. Many of them are now holding the director positions with highly competitive benefit packages. The corporate culture is transparent, result oriented and fast decision making. The company nurtures and supports the creativity and originality of ideas. The working environment allows talents to prosper and promote quickly. | $90M | Private Equity | Jan 18, 2022 |  |
| Encube Ethicals | Encube Ethicals a contract development and manufacturing organization, specializes in topical semisolid formulations. |  | Private Equity | Jun 28, 2021 |  |

10 of 27 investments shown.

## Co-investors
- [Lightrock india (Aspada)](https://shizune.co/investors/profile/aspada) — VC Fund, 4 deals together
- [TEAMFund](https://shizune.co/investors/profile/teamfund) — VC Fund, 4 deals together
- [Alteria Capital](https://shizune.co/investors/profile/alteria-capital) — VC Fund, 2 deals together
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 2 deals together
- [FinSight Ventures](https://shizune.co/investors/profile/finsight-ventures) — VC Fund, 2 deals together
- [India Life Sciences Fund III](https://shizune.co/investors/profile/india-life-sciences-fund-iii) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in India](https://shizune.co/investors/medical-investors-india)
- [Medical VC Funds in India](https://shizune.co/investors/medical-vc-funds-india)
- [Biotech VC Funds in India](https://shizune.co/investors/biotech-vc-funds-india)

## FAQ

### What does Quadria Capital invest in?

Quadria Capital invests primarily in Health Care, Medical and Manufacturing startups, most often at Private Equity and Funding Round stage. Most of the 27 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Quadria Capital's check size?

Quadria Capital typically joins rounds of $13M–$100M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Quadria Capital participates in.

### How do I contact Quadria Capital?

Public channels for Quadria Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Quadria Capital?

The team at Quadria Capital includes Amit Varma (Co-founder & Managing Partner), Sunil Thakur (Director) and Abrar Mir (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co